MARÍA NIEVES
CABRERA MARTÍN
Profesora asociada de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (41)
2024
-
Correction to: Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography (EJNMMI Physics, (2024), 11, 1, (12), 10.1186/s40658-024-00618-2)
EJNMMI Physics
-
Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography
EJNMMI Physics, Vol. 11, Núm. 1
-
Response to Yilmaz et al.
Anti-Cancer Drugs
2023
-
Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer
Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698
-
Metabolic characterization of structural lung changes in patients with findings suggestive of incidental COVID-19 pneumonia on 18F-FDG PET/CT: Pathophysiological insights from multimodal images obtained during the pandemic
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 6, pp. 380-387
-
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
Oncology Letters, Vol. 25, Núm. 1
2022
-
Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing 18F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 63, Núm. 2, pp. 274-279
-
Intracranial desmoplastic small round cell tumor after childhood acute myeloid leukemia treated with metronomic oral cyclophosphamide
Pediatric Blood and Cancer
-
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
Frontiers in Oncology, Vol. 12
-
Staging of primary cardiac lymphoma through 18F-FDG PET/CT with extrathoracic extension
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 266-267
2021
-
Assessment of extra-parenchymal lung involvement in asymptomatic cancer patients with COVID-19 pneumonia detected on 18F-FDG PET-CT studies
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 768-776
-
Incidental 68Ga-DOTATOC PET/CT Uptake in Hemorrhagic Transformation of Stroke in a Patient With Cervical Paraganglioma
Clinical nuclear medicine, Vol. 46, Núm. 12, pp. e565-e566
-
Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient
Anti-Cancer Drugs, Vol. 32, Núm. 5, pp. 580-584
-
Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer
Oral Oncology
-
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035
2020
-
Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer
Oral Oncology
-
Relevance of quantification in brain PET studies with 18F-FDG
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 3, pp. 184-192
-
Teragnosis en medicina nuclear
Anales de la Real Academia Nacional de Medicina, Núm. 137, pp. 54-59
2019
-
Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer
Head and Neck, Vol. 41, Núm. 6, pp. E86-E92
-
Response to immunotherapy rechallenge after interval chemotherapy in a patient with head and neck cancer
Anti-Cancer Drugs, Vol. 30, Núm. 2, pp. 149-152